Skip to content

Comparing Dexmedetomidine and Magnesium Sulfate for Blood Pressure Control During Spine Surgery Intubation

A prospective comparative study of effects of intravenous dexmedetomidine versus intravenous magnesium sulfate in attenuating hemodynamic stress responses during laryngoscopy and endotracheal intubation in spine surgeries. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083894
Enrollment
52
Registered
2025-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group D receive Inj. Dexmedetomidine 1.5 mcg/kg i.v.: Group D will receive Inj. Dexmedetomidine 1.5 mcg/kg i.v. diluted in 100ml Normal Saline over 20 minutes before induction of gener

Sponsors

Smt Bhikiben Kanjibhai Shah Medical Institute and Research Cen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to sign written & informed consent. Male or female patients between ages of 18 to 60 years. Patients belonging to American Society of Anesthesiologists (ASA) physical status I and II. Patients posted for elective spine surgeries under general anesthesia

Exclusion criteria

Exclusion criteria: Patients unwilling to participate in the study. Patients with cardiovascular, cerebrovascular, hepatic and renal diseases. Patients having arrhythmias or heart block. Psychiatric patients. Pregnancy & lactating women. Patients taking beta blockers. History of allergy to the study drugs. Anticipated difficult airway. BMI greater than 30 Patient having Neuromuscular disease Serum magnesium level greater than 2.5mEq per L

Design outcomes

Primary

MeasureTime frame
This prospective and observational study will help us to compare the efficacy of intravenous Dexmedetomidine versus intravenous Magnesium sulphate for attenuation of the pressor response to larngoscopy and endotracheal intubation and will enable us to know which of the two drugs is most beneficial in providing better attenuation of the hemodynamic response to larngoscopy and endotracheal intubation.Timepoint: Monitoring of parameters i.e. HR, SBP, DBP, MAP, SPO2 will be noted at baseline, after administration of test drug, after induction, during laryngoscopy and intubation and at 1,3,5 minutes after intubation.

Secondary

MeasureTime frame
To study sedation score after extubation or any side effects.Timepoint: Ramsay sedation score (RSS) will be recorded at 1 minutes for 30 minutes 60 minutes and 90 minutes.

Countries

India

Contacts

Public ContactDr Jatin Patel

Smt. Bhikiben Kanjibhai Shah Medical Institute and Research Centre

Dr_jatinpatel@yahoo.co.in9879368363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026